Your browser doesn't support javascript.
loading
Impact of ellagic acid application on doxorubicin-induced cardiovascular toxicity model.
Salinger-Martinovic, Sonja; Cosic, Vladan; Stojiljkovic, Nenad; Ilic, Sonja; Stojanovic, Nikola; Dencic, Tijana.
Afiliación
  • Salinger-Martinovic S; Clinic for Cardiovascular Diseases, Clinical Center Nis, Blvd dr Zorana Djindjica 48, Nis, Serbia.
  • Cosic V; Department of Cardiology, University of Nis, Faculty of Medicine, Blvd dr Zorana Djindjica 81, Serbia.
  • Stojiljkovic N; Clinical Center Nis, Blvd dr Zorana Djindjica 48, Nis, Serbia.
  • Ilic S; Department of Physiology, University of Nis, Faculty of Medicine, Blvd dr Zorana Djindjica 81, Nis, Serbia.
  • Stojanovic N; Department of Physiology, University of Nis, Faculty of Medicine, Blvd dr Zorana Djindjica 81, Nis, Serbia.
  • Dencic T; Department of Physiology, University of Nis, Faculty of Medicine, Blvd dr Zorana Djindjica 81, Nis, Serbia.
Can J Physiol Pharmacol ; 99(2): 185-191, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33509026

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Ácido Elágico / Corazón Límite: Animals Idioma: En Revista: Can J Physiol Pharmacol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Ácido Elágico / Corazón Límite: Animals Idioma: En Revista: Can J Physiol Pharmacol Año: 2021 Tipo del documento: Article
...